Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03557541
Other study ID # 2013/8863
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2014
Est. completion date July 2017

Study information

Verified date July 2018
Source Institut d'Investigacions Biomèdiques August Pi i Sunyer
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The hypothesis formulated is that 200 g of sardine on a weekly basis will have a favourable impact avoiding the natural development of the pathology due to changes in the biochemical profile, the anthropometrics, inflammatory markers, changes in gut microbiota populations, also in transcriptomics and metabolomics.


Recruitment information / eligibility

Status Completed
Enrollment 182
Est. completion date July 2017
Est. primary completion date July 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria:

- glycaemia between 100-125 md / dL or =5.7% HbA1c

Exclusion Criteria:

- treatment with oral antidiabetic drugs

- any nutritional education to prevent T2D

- Suspect or known hypersensitivity to sardine or related fish

- Chronic treatment with oral steroids and / or AINES

- Treatment with oral antidiabetic agents and / or insulin

- Treatment with immunosuppressive drugs

- Diagnosis of active neoplasm

- Diagnosis of HIV or AIDS

- Abnormal liver profile (> 6 times normal values)

- Diagnosis of Acute Psychiatric Sdr

- Presence of serious acute concomitant disease, which it requires more than 7 days of recovery.

- Major cardiovascular event (stroke, myocardial infarction) in the month prior to randomization.

- Any other condition that the investigator considers to be inoperative so that the subject conducts the study.

Study Design


Intervention

Dietary Supplement:
Sardine
They received 200gr of canned sardine in olive oil per week (+a common T2D-preventive diet)
Control
They received a common T2D-preventive diet

Locations

Country Name City State
Spain Diana A Diaz Rizzolo Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Institut d'Investigacions Biomèdiques August Pi i Sunyer

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary type 2 diabetes new onset incidence of new diagnosis of type 2 diabetes Change from Baseline at 12 months
Secondary adiponectin adiponectin levels Change from Baseline at 12 months
Secondary quantification of gut microbiota populations quantification by q-PCR Change from Baseline at 12 months
Secondary gene expression relative expression related genes by RT q-PCR (Real Time Quantitative Reverse transcription polymerase chain reaction) Change from Baseline at 12 months
Secondary metabolomics study of dietary biomarkers and health biomarkers [(1) Fatty acyls, bile acids, steroids and lysoglycerophospholipids, (2) Glycerolipids, glycerophospholipids, sterol lipids and sphingolipids, (3) Amino acids.] endogenous metabolic profiles of serum samples will be studied using ultra-high performance liquid chromatography - mass spectrometry (UHPLC-MS). The same unit for measurements [log2 (fold change)] Change from Baseline at 12 months
Secondary glucose homeostasis glucose (mg/dl) Change from Baseline at 12 months
Secondary insulin levels insulin (mU/L) Change from Baseline at 12 months
Secondary HOMA-IR (homeostasis model assessment insulin resistance) insulin resistance index Change from Baseline at 12 months
Secondary HOMA-B (homeostasis model assessment B cell function) B cella function Change from Baseline at 12 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2